This site is currently in beta and not available to the public. Please enter your access code to continue.
My Neuro Shield delivers precision neurological therapy through our breakthrough atomizer technology — crossing the blood-brain barrier to restore, protect, and optimize brain function.
My Neuro Shield is powered by the ViaNase™ Platform from Kurve Therapeutics — a clinically validated intranasal drug delivery system engineered to transport therapeutic compounds directly across the blood-brain barrier with precision and consistency.
The ViaNase platform leverages targeted olfactory and trigeminal nerve pathways to deliver compounds directly into the CNS — bypassing the blood-brain barrier entirely.
Kurve's proprietary vortex atomization generates precisely sized aerosol particles that deposit in the upper nasal cavity, maximizing uptake and minimizing systemic exposure.
Every ViaNase treatment protocol is informed by blood biomarker testing, ensuring personalized delivery of the right compounds at the right dose for each individual.
Ongoing biomarker monitoring tracks neurological response over time, giving patients and providers objective, data-backed evidence of brain health progress.
Our atomizer platform delivers a precisely formulated combination of bioactive compounds proven to support neurological regeneration, repair, and protection.
Supports neuronal glucose metabolism and promotes neuroprotective signaling pathways critical for cognitive function.
Immunoglobulin G helps modulate neuroinflammation and supports immune balance within the central nervous system.
Nano-sized vesicles that act as cellular messengers, delivering regenerative signals and promoting neural repair at the molecular level.
Mesenchymal stem cells with powerful anti-inflammatory and neuroregenerative properties that support brain tissue healing and recovery.
Multilineage-differentiating stress enduring cells — a breakthrough in regenerative medicine shown to self-migrate to sites of neural injury.
Targeted neuropeptides act as biological messengers that regulate neuronal activity, modulate inflammation, support synaptic function, and promote neuroprotection — including applications for PTSD, cognitive decline, and CNS disorders.
My Neuro Shield's platform is being explored across a broad spectrum of neurological areas through ongoing investigational research.
Traumatic brain injury and concussion can have lasting neurological effects. Our compounds support acute recovery and long-term brain health restoration for athletes and patients alike.
Targeting the neuroinflammation and cellular deterioration underlying Alzheimer's, our platform delivers neuroprotective agents directly to affected brain regions.
Addressing neuroinflammation and immune dysregulation associated with autism spectrum conditions through targeted bioactive compound delivery.
Pediatric Acute-onset Neuropsychiatric Syndrome driven by immune response — our IgG and anti-inflammatory compounds help modulate the neurological impact.
Supporting dopaminergic neuron health and reducing neuroinflammation associated with Parkinson's through our regenerative stem cell and exosome delivery.
Targeting myelin repair and neuroinflammation in MS with MSC stem cells and MUSE cells shown to support remyelination and neural regeneration.
Chronic neuroinflammation underlies many brain conditions. Our multi-compound approach targets inflammation pathways to restore neural homeostasis.
My Neuro Shield's platform is designed to meet the needs of individuals, medical professionals, and sports organizations.
Individuals and families seeking cutting-edge brain health solutions outside traditional healthcare limitations. Our at-home atomizer makes advanced neurotherapy accessible.
Forward-thinking physicians and clinics integrating My Neuro Shield into their regenerative medicine protocols for neurological patient care and outcome optimization.
Professional teams, athletic programs, and trainers seeking evidence-based concussion recovery and cognitive performance protocols for their athletes.
Everything you need for comprehensive brain health monitoring and treatment.
Our flagship blood-brain barrier penetrating atomizer device for at-home or clinical administration of neuroregenerative compounds.
Includes biomarker testing panel, baseline assessment, atomizer starter formula, and a personalized treatment protocol consultation.
Comprehensive neurological blood biomarker testing panel to establish your baseline and monitor ongoing brain health and treatment response.
Our full biologics formulary — delivered via the ViaNase platform to cross the blood-brain barrier and support neurological repair and regeneration.
We monitor neurological health through a precision set of blood biomarkers — objective, measurable indicators of brain injury, neurodegeneration, and genetic risk. Select a biomarker below to learn more.
Astrocyte Damage Marker
GFAP is a structural protein found exclusively in astrocytes — the support cells of the brain. When brain tissue is injured or undergoing neurodegeneration, astrocytes release GFAP into the bloodstream, making it a highly sensitive blood-based indicator of brain damage.
Axonal Injury & Neurodegeneration Marker
NfL is a structural protein that forms part of the internal scaffolding of neurons (neurofilaments). When axons — the long nerve fibers that transmit signals between neurons — are damaged or destroyed, NfL is released into the cerebrospinal fluid and bloodstream.
Neuronal Injury & Tau Pathology Marker
BD-Tau is a form of the tau protein that originates specifically from neurons in the brain. Unlike total tau measurements that can include tau from peripheral tissues, BD-Tau is brain-specific — providing a cleaner signal of neuronal damage and tau-related pathology.
Genetic Risk & Personalized Medicine Marker
APOE (Apolipoprotein E) is a gene with three variants — ε2, ε3, and ε4 — that plays a critical role in how the brain processes and clears fats, repairs neurons, and manages amyloid beta. Knowing a patient's APOE genotype is one of the most powerful tools in personalized brain health.
Alzheimer's Pathology & Amyloid Cascade Marker
P-Tau 217 is a form of the tau protein that has been abnormally phosphorylated at a specific site — threonine-217 — a modification driven almost exclusively by the accumulation of amyloid beta plaques in the brain. It is one of the most accurate blood-based indicators of Alzheimer's disease pathology currently available.
Both BD-Tau and P-Tau 217 are forms of the tau protein, but they measure fundamentally different biological events and serve distinct clinical purposes. Understanding which tau marker to use — and when — is essential to accurate neurological assessment.
Brain-Derived Tau
Phosphorylated Tau at Threonine-217
Establish your neurological health baseline with our full GFAP, NfL, BD-Tau, and APOE panel before beginning any protocol.
Results guide a customized treatment protocol — tailored to your biomarker profile, APOE genotype, and neurological needs.
Repeat testing tracks progress, measures neurological improvements, and informs protocol adjustments over time.
Objective biomarker evidence of your brain health changes — measurable, trackable, and actionable.
The following research has been conducted or facilitated using the Kurve ViaNase intranasal delivery platform. Click any study to open the full PDF.
Research sourced from kurveresearch.com. All studies are investigational. Results are not a guarantee of outcomes. Consult a licensed physician before beginning any protocol.
Whether you're a patient, provider, or sports organization — My Neuro Shield has a solution designed for you. Start with a consultation today.
Have questions about our technology, products, or partnership opportunities? We'd love to connect.